NO20004141L - Nye substituerte pyridino arylpiperaziner er anvendelige ved behandling av benign prostata hyperplasi - Google Patents

Nye substituerte pyridino arylpiperaziner er anvendelige ved behandling av benign prostata hyperplasi

Info

Publication number
NO20004141L
NO20004141L NO20004141A NO20004141A NO20004141L NO 20004141 L NO20004141 L NO 20004141L NO 20004141 A NO20004141 A NO 20004141A NO 20004141 A NO20004141 A NO 20004141A NO 20004141 L NO20004141 L NO 20004141L
Authority
NO
Norway
Prior art keywords
arylpiperazines
useful
treatment
benign prostate
prostate hyperplasia
Prior art date
Application number
NO20004141A
Other languages
English (en)
Other versions
NO317103B1 (no
NO20004141D0 (no
Inventor
Gee-Hong Kuo
William V Murray
Catherine P Prouty
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20004141D0 publication Critical patent/NO20004141D0/no
Publication of NO20004141L publication Critical patent/NO20004141L/no
Publication of NO317103B1 publication Critical patent/NO317103B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20004141A 1998-02-20 2000-08-18 Nye substituerte pyridino arylpiperaziner er anvendelige ved behandling av benign prostata hyperplasi NO317103B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (3)

Publication Number Publication Date
NO20004141D0 NO20004141D0 (no) 2000-08-18
NO20004141L true NO20004141L (no) 2000-10-19
NO317103B1 NO317103B1 (no) 2004-08-09

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004141A NO317103B1 (no) 1998-02-20 2000-08-18 Nye substituerte pyridino arylpiperaziner er anvendelige ved behandling av benign prostata hyperplasi

Country Status (23)

Country Link
US (1) US6218396B1 (no)
EP (1) EP1054868B1 (no)
JP (1) JP2002503724A (no)
KR (1) KR100591028B1 (no)
CN (1) CN1121390C (no)
AR (1) AR014626A1 (no)
AT (1) ATE250580T1 (no)
AU (1) AU766398B2 (no)
BR (1) BR9909647A (no)
CZ (1) CZ294136B6 (no)
DE (1) DE69911582T2 (no)
DK (1) DK1054868T3 (no)
ES (1) ES2209468T3 (no)
HU (1) HUP0100781A3 (no)
IL (2) IL137954A0 (no)
NO (1) NO317103B1 (no)
NZ (1) NZ506462A (no)
PL (1) PL342339A1 (no)
PT (1) PT1054868E (no)
TR (1) TR200003220T2 (no)
TW (1) TW565555B (no)
WO (1) WO1999042448A1 (no)
ZA (1) ZA991315B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071915A (en) * 1997-05-12 2000-06-06 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
KR100852362B1 (ko) 2000-08-08 2008-08-14 오르토-맥네일 파마슈티칼, 인코퍼레이티드 비-이미다졸 아릴옥시피페리딘
JP3878178B2 (ja) * 2001-12-28 2007-02-07 武田薬品工業株式会社 排尿障害予防治療剤
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
US8470859B2 (en) 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CL2009000964A1 (es) * 2008-04-23 2010-03-26 Takeda Pharmaceuticals Co Compuestos derivados de 1-aril-2-imino-1,2-dihidropiridina-3-carboxamida, antagonista del receptor adrenergico alfa 1d, composicion farmaceutica que los comprende; y su uso para el tratamiento o profilaxis de enfermedades del tracto urinario inferior.
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
WO1999003833A1 (fr) * 1997-07-15 1999-01-28 Sankyo Company, Limited Derives de piperazine

Also Published As

Publication number Publication date
PT1054868E (pt) 2004-01-30
EP1054868A1 (en) 2000-11-29
CZ294136B6 (cs) 2004-10-13
KR100591028B1 (ko) 2006-06-22
IL137954A0 (en) 2001-10-31
CN1291188A (zh) 2001-04-11
AR014626A1 (es) 2001-03-28
AU3302599A (en) 1999-09-06
ES2209468T3 (es) 2004-06-16
TW565555B (en) 2003-12-11
NO317103B1 (no) 2004-08-09
IL137954A (en) 2007-06-03
NO20004141D0 (no) 2000-08-18
ZA991315B (en) 2000-11-20
WO1999042448A1 (en) 1999-08-26
HUP0100781A2 (hu) 2001-08-28
KR20010041115A (ko) 2001-05-15
CZ20003044A3 (cs) 2001-04-11
AU766398B2 (en) 2003-10-16
US6218396B1 (en) 2001-04-17
CN1121390C (zh) 2003-09-17
PL342339A1 (en) 2001-06-04
HUP0100781A3 (en) 2002-12-28
EP1054868B1 (en) 2003-09-24
DE69911582D1 (de) 2003-10-30
DE69911582T2 (de) 2005-09-15
NZ506462A (en) 2003-07-25
HK1030776A1 (en) 2001-05-18
BR9909647A (pt) 2000-11-21
DK1054868T3 (da) 2003-12-22
TR200003220T2 (tr) 2001-04-20
ATE250580T1 (de) 2003-10-15
JP2002503724A (ja) 2002-02-05

Similar Documents

Publication Publication Date Title
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
DE69927128D1 (de) Verwendung von topisch applizierbaren Gerinnungsmaterial
DK0925069T3 (da) Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
NO992069D0 (no) Konjugater som kan anvendes ved behandling av prostatakreft
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
NO991619D0 (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
NO20004141D0 (no) Nye substituerte pyridinoarylpiperaziner er anvendelige ved behandling av benign prostatahyperplasi
NO20002804D0 (no) Konjugater som kan anvendes ved behandling av prostatakreft
PT984777E (pt) Piperazinas arilsubstituidas uteis no tratamento da hiperplasia benigna da prostata
NO994258D0 (no) Anvendelse av levobupivakain eller ropivakain for behandling av migrene
DE69814993D1 (de) Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen
DE60008363D1 (de) Flammhemmende mischung welche monomere und oligomere flammhemmer enthält
NO20030593D0 (no) Fremgangsmåter for behandling av cancer og smerten forbundet derved ved å anvende endotelinantagonister
HUP9904408D0 (en) Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
NO20004142D0 (no) Ftalimidoarylpiperaziner som <alfa> 1A reseptorantagonister anvendelige ved behandling av benign prostatahyperplasi
NO975838D0 (no) Melatoninagonister for behandling av godartet prostatisk hyperplasi
NO20005062D0 (no) Behandling av panikkanfall
DK1135128T3 (da) Nye behandlingsfremgangsmåder
DE59910283D1 (de) Authentifizierung von schlüsselgeräten
HK1022648A (zh) 治疗偏头痛的药物
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
FI980212A0 (fi) Anordning och foerfarande foer infoerande av en massabanas spets i en cellulosatork
KR970052375U (ko) 자외선살균 식기건조기 및 전자레인지용 도어
DK0859899T3 (da) Dørlås som valgfrit kan anvendes højre- eller venstregående

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees